Rite Aid Corporation (RAD)
(Delayed Data from NYSE)
$8.77 USD
-0.03 (-0.34%)
Updated May 3, 2019 04:02 PM ET
After-Market: $8.75 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.77 USD
-0.03 (-0.34%)
Updated May 3, 2019 04:02 PM ET
After-Market: $8.75 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Pharmacies & Drug Stores Industry Boasts Bright Prospects
by Urmimala Biswas
The Retail - Pharmacies and Drug Stores industry witnesses heavy consolidation.
Factors Likely to Influence Stitch Fix (SFIX) Earnings in Q4
by Zacks Equity Research
Although solid performance in men's category and better margins are likely to contribute to Stitch Fix's (SFIX) Q4 results, high costs remains a matter of concern.
Implied Volatility Surging for Rite Aid (RAD) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Rite Aid (RAD) stock based on the movements in the options market lately.
Rite Aid (RAD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Rite Aid (RAD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Things You Must Know Prior to Rite Aid's (RAD) Q2 Earnings
by Zacks Equity Research
Rite Aid (RAD) gains from increased immunizations and clinical pharmacy services, which are likely to continue. Decline in prescription reimbursement rates is a headwind.
Rite Aid (RAD) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Rite Aid (RAD) closed the most recent trading day at $7.13, moving +1.57% from the previous trading session.
Rite Aid (RAD) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Rite Aid (RAD) closed the most recent trading day at $5.39, moving +1.51% from the previous trading session.
Rite Aid (RAD) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Rite Aid (RAD) closed the most recent trading day at $5.77, moving +1.76% from the previous trading session.
Rite Aid (RAD) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Rite Aid (RAD) closed at $6.98, marking a +0.58% move from the previous day.
Rite Aid (RAD) Down 23.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Rite Aid Expands in Northeast With Thrifty Ice Cream Brand
by Zacks Equity Research
Rite Aid (RAD) expands the availability of its Thrifty Ice Cream brand in select stores in Delaware, New York, Maryland, New Jersey and Pennsylvania.
Will Amazon (AMZN) be Rite-Aid's (RAD) Bandage?
by Mitchell Moore
Rite Aid Corporation (RAD) posted its Q1 2020 earnings results on Wednesday, June 26, after market close. This report was disappointing with an adjusted loss of -$0.14 per share, a steep dive from our zacks Consensus Estimate of +$0.02.
Rite Aid (RAD) Incurs Loss in Q1, Revenues Decline Y/Y
by Zacks Equity Research
Rite Aid (RAD) incurs loss in first-quarter fiscal 2020. However, it reaffirms outlook for the fiscal year.
Options Traders Expect Huge Moves in Rite Aid (RAD) Stock
by Zacks Equity Research
Investors need to pay close attention to Rite Aid (RAD) stock based on the movements in the options market lately.
Rite Aid (RAD) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rite Aid (RAD) delivered earnings and revenue surprises of -800.00% and 0.02%, respectively, for the quarter ended May 2019. Do the numbers hold clues to what lies ahead for the stock?
Herbalife (HLF) Jumps: Stock Rises 5.7%
by Zacks Equity Research
Herbalife (HLF) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Rite Aid (RAD) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Rite Aid (RAD) Beat on Earnings in Q1 Despite Soft View?
by Zacks Equity Research
Rite Aid's (RAD) first-quarter fiscal 2020 results should gain from growth initiatives, and momentum in retail and pharmacy businesses. However, a bleak outlook raises concerns.
Rite Aid Partners with Adobe, Digital Business to Benefit
by Zacks Equity Research
Rite Aid (RAD) partners with Adobe to accelerate digital transformation and boost customer experience across all channels.
Rite Aid (RAD) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Rite Aid (RAD) closed at $8.93, marking a +1.59% move from the previous day.
Rite Aid (RAD) Down 22.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Rite Aid (RAD) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Rite Aid (RAD) closed the most recent trading day at $8.08, moving -0.62% from the previous trading session.
Lockheed Martin, Rite Aid, Avid Technology, NeoPhotonics and EXFO highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Lockheed Martin, Rite Aid, Avid Technology, NeoPhotonics and EXFO highlighted as Zacks Bull and Bear of the Day
Bear Of The Day: Rite Aid (RAD)
by Daniel Laboe
Rite Aid (RAD) has had a devastating past 3 year, having lost 95% of its total market value in that time frame. RAD is currently the most shorted stock in America today, with 390% of free-floating shares being held short.
Bear Of The Day: Rite Aid (RAD)
by Daniel Laboe
Rite Aid (RAD) has had a devastating past 3 year, having lost 95% of its total market value in that time frame. RAD is currently the most shorted stock in America today, with 390% of free-floating shares being held short.